Quick Takeaways
- Endeavour Medtech Growth II LP filed SCHEDULE 13G for Kestra Medical Technologies, Ltd. Common Shares, par value $1.00 per share (KMTS).
- Disclosed ownership: 5.2%.
- Date of event: 31 Mar 2025.
Endeavour Medtech Growth II LP - 31 Mar 2025 SCHEDULE 13G Report for Kestra Medical Technologies, Ltd. Common Shares, par value $1.00 per share (KMTS)
- Filing Manager
- Endeavour Medtech Growth II LP
- Reporting Manager
- Endeavour Medtech Growth II LP
- Symbol
- KMTS
- Shares outstanding
- 50,901,904 shares
- Disclosed Ownership
- 2,646,899 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 15 May 2025, 16:05:32 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Endeavour Medtech Growth II LP disclosed 5.2% ownership in Kestra Medical Technologies, Ltd. Common Shares, par value $1.00 per share (KMTS) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Endeavour Medtech Growth II LP | 5.2% | 2,646,899 | 0 | 2,646,899 | /s/ Nick Barton | Nick Barton, Director of Endeavour Medtech II GP Limited, its General Partner | |
| Endeavour Medtech Growth II Parallel LP | 5.2% | 2,646,899 | 0 | 2,646,899 | /s/ Nick Barton | Nick Barton, Director of Endeavour Medtech II GP Limited, its General Partner | |
| Endeavour Medtech II GP Limited | 5.2% | 2,646,899 | 0 | 2,646,899 | /s/ Nick Barton | Nick Barton, Director |